Dr. Young Kwang Chae
Claim this profileNorthwestern University
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
12 reported clinical trials
23 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
Stage II
2Non-Small Cell Lung Cancer
Stage IV
Stage III
RET positive
Affiliated Hospitals
Clinical Trials Young Kwang Chae is currently running
Pre-Surgery Immunotherapy
for Mesothelioma
This trial tests if giving immunotherapy drugs can better control disease in patients with a specific type of mesothelioma. The drugs help the immune system attack cancer cells, which may stop the cancer from growing and spreading.
Recruiting1 award Phase 227 criteria
Ramucirumab + Pembrolizumab vs Chemotherapy
for Non-Small Cell Lung Cancer
This phase III trial compares the effect of the combination of ramucirumab and pembrolizumab versus standard of care chemotherapy for the treatment of non-small cell lung cancer that is stage IV or that has come back after a period of improvement (recurrent). Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial may help doctors find out if giving ramucirumab with pembrolizumab is more effective at treating patients with stage IV or recurrent non-small cell lung cancer than standard chemotherapy.
Recruiting2 awards Phase 310 criteria
More about Young Kwang Chae
Clinical Trial Related7 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Young Kwang Chae has experience with
- Pembrolizumab
- Nivolumab
- Ramucirumab
- Talazoparib
- Ipilimumab
- Pemetrexed
Breakdown of trials Young Kwang Chae has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Relapse
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Young Kwang Chae specialize in?
Young Kwang Chae focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Young Kwang Chae currently recruiting for clinical trials?
Yes, Young Kwang Chae is currently recruiting for 5 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Young Kwang Chae has studied deeply?
Yes, Young Kwang Chae has studied treatments such as Pembrolizumab, Nivolumab, Ramucirumab.
What is the best way to schedule an appointment with Young Kwang Chae?
Apply for one of the trials that Young Kwang Chae is conducting.
What is the office address of Young Kwang Chae?
The office of Young Kwang Chae is located at: Northwestern University, Chicago, Illinois 60611 United States. This is the address for their practice at the Northwestern University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.